UA109179C2 - SOLID DOSAGE FORM AND METHOD OF PREPARATION - Google Patents

SOLID DOSAGE FORM AND METHOD OF PREPARATION

Info

Publication number
UA109179C2
UA109179C2 UAA201310538A UAA201310538A UA109179C2 UA 109179 C2 UA109179 C2 UA 109179C2 UA A201310538 A UAA201310538 A UA A201310538A UA A201310538 A UAA201310538 A UA A201310538A UA 109179 C2 UA109179 C2 UA 109179C2
Authority
UA
Ukraine
Prior art keywords
solid dosage
dosage form
preparation
dosage forms
retino
Prior art date
Application number
UAA201310538A
Other languages
Russian (ru)
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAA201310538A priority Critical patent/UA109179C2/en
Publication of UA109179C2 publication Critical patent/UA109179C2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід належить до галузі фармацевтичної промисловості, а саме до твердих дозованих лікарських форм, що можуть бути використані для профілактики та лікування ускладнень цукрового діабету І та II типів і алкоголізму, зокрема діабетичних ангіо-, нейро-, ретино- та нефропатій та алкогольних нейропатій, а також до способів одержання зазначених лікарських форм. Тверда дозована лікарська форма як активні речовини містить тіоктову кислоту, таурин і бенфотіамін.The invention relates to the field of pharmaceutical industry, namely solid dosage forms that can be used for the prevention and treatment of complications of diabetes mellitus type I and II and alcoholism, in particular diabetic angio-, neuro-, retino- and nephropathies and alcoholic neuropathies, and also to methods of preparing said dosage forms. The solid dosage form as the active substance contains thioctic acid, taurine and benfotiamine.

UAA201310538A 2013-08-30 2013-08-30 SOLID DOSAGE FORM AND METHOD OF PREPARATION UA109179C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201310538A UA109179C2 (en) 2013-08-30 2013-08-30 SOLID DOSAGE FORM AND METHOD OF PREPARATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201310538A UA109179C2 (en) 2013-08-30 2013-08-30 SOLID DOSAGE FORM AND METHOD OF PREPARATION

Publications (1)

Publication Number Publication Date
UA109179C2 true UA109179C2 (en) 2015-07-27

Family

ID=53721174

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201310538A UA109179C2 (en) 2013-08-30 2013-08-30 SOLID DOSAGE FORM AND METHOD OF PREPARATION

Country Status (1)

Country Link
UA (1) UA109179C2 (en)

Similar Documents

Publication Publication Date Title
EA201890883A1 (en) VACUUM DISTILLATION FOR ENRICHING CANNABIDIOL
MX2016007067A (en) Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology.
UA110054C2 (en) 3-Phenylpropionic Acid Branched Branches and Their Applications
EA201490546A1 (en) SUBSTITUTED ANNELED PYRIMIDINES AND THEIR APPLICATION
EA201590251A1 (en) NEW 5-AMINOTETRAHYDROHINOLIN-2-CARBONIC ACIDS AND THEIR APPLICATION
EA201690520A1 (en) METHOD OF OBTAINING SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINES
UA113774C2 (en) POLYMER NANOPARTICLES CONTAINING FINASTERIDE AND MINOXIDIL, METHOD OF MANUFACTURING THEREOF;
EA201591618A1 (en) SUBSTITUTED IMIDAZOPIRIDAZINES
PH12015502535A1 (en) Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
EA201492040A1 (en) BICYCLICALLY SUBSTITUTED URACILES AND THEIR APPLICATION
BR112016008576A2 (en) STABLE AQUEOUS FORMULATIONS OF ANTIBODIES AND PHARMACEUTICAL UNIT DOSAGE FORM
EA201391488A1 (en) COMPOSITIONS WITH REDUCED VISCOSITY
EA201592227A1 (en) STABLE SOLUTIONS OF UNITED ACTIVE PHARMACEUTICAL INGREDIENTS FOR ORAL APPLICATION
UA113962C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT
EA201590892A1 (en) DERIVATIVES N- (PYRIDIN-2-IL) Pyrimidine-4-amine, containing a sulfoximine group
EA201600288A1 (en) SUBSTITUTED PHYLALANINE DERIVATIVES
EA201690183A1 (en) SUBSTITUTED PYRAZOLOPIRIDINAMINES
CL2012002893A1 (en) Composition of at least one active ingredient of vegetable or synthetic origin thereof, or extract of plant origin containing it, in an aqueous solution, which also comprises lecithin as an encapsulating agent; medicine that understands it; method for its preparation; and its use to treat intestinal parasitosis.
EA201690005A1 (en) COMPOSITION WITH MODIFIED EXTRUSION KINETICS
MY189459A (en) Anti-cancer agents and preparation thereof
MX2016008397A (en) Composition for use in the treatment of persistent cough.
AR100618A1 (en) PREPARATION PROCEDURE FOR HUMAN ALBUMIN WITH REDUCED DISSOLVED OXYGEN LEVEL
EA201401117A1 (en) COMPOSITIONS CONTAINING PROBIOTICS AND COMPLEX OF BEE POULTRY / CLAY, METHOD OF THEIR PREPARATION AND THEIR APPLICATION IN FOOD AND THERAPY
EA201792143A1 (en) MEDICAL FORM FOR LONG-TERM EXTRACTING OF EXISTING SUBSTANCES
EA201500245A1 (en) SOLID PHARMACEUTICAL PREPARATION THAT CONTAINS LEVOTIROXIN